Microalgae Oil Supplement segmentation by type distinguishes four chemically defined categories that determine functional performance and pricing. EPA‑rich oil, containing ≥50 % eicosapentaenoic acid, commands the highest premium and supplies roughly 35 % of market volume, driven by cardiovascular‑risk reduction claims. DHA‑rich oil, with ≥50 % docosahexaenoic acid, accounts for about 30 % and is favored in prenatal and cognitive‑health applications. Mixed‑omega‑3 blends, balancing EPA and DHA in a 1:1 to 2:1 ratio, represent 25 % of sales, offering broader health benefits and greater formulation flexibility. Full‑spectrum extracts retain minor carotenoids, sterols, and chlorophyll, contributing the remaining 10 % and targeting niche antioxidant or skin‑care markets. Each type’s contribution to overall market size reflects both raw‑material costs and end‑use value perception; higher EPA/DHA concentrations drive higher price points, whereas full‑spectrum products rely on differentiated functional claims to justify their share. This taxonomy enables manufacturers to align production lines with specific demand clusters, optimizing capacity utilization across the Microalgae Oil Supplement market.